RU2015155470A - Высокоэффективные фармацевтические композиции панкреатина - Google Patents
Высокоэффективные фармацевтические композиции панкреатина Download PDFInfo
- Publication number
- RU2015155470A RU2015155470A RU2015155470A RU2015155470A RU2015155470A RU 2015155470 A RU2015155470 A RU 2015155470A RU 2015155470 A RU2015155470 A RU 2015155470A RU 2015155470 A RU2015155470 A RU 2015155470A RU 2015155470 A RU2015155470 A RU 2015155470A
- Authority
- RU
- Russia
- Prior art keywords
- pancreatin
- stage
- solvent
- mpa
- hildebrand
- Prior art date
Links
- 108010019160 Pancreatin Proteins 0.000 title claims 34
- 229940055695 pancreatin Drugs 0.000 title claims 34
- 239000000203 mixture Substances 0.000 title claims 19
- 238000000034 method Methods 0.000 claims 53
- 239000002904 solvent Substances 0.000 claims 25
- 239000003960 organic solvent Substances 0.000 claims 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 18
- 239000003125 aqueous solvent Substances 0.000 claims 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 13
- 239000007853 buffer solution Substances 0.000 claims 13
- 235000019626 lipase activity Nutrition 0.000 claims 11
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims 9
- 230000000694 effects Effects 0.000 claims 6
- 239000000725 suspension Substances 0.000 claims 6
- 238000001035 drying Methods 0.000 claims 5
- 239000000243 solution Substances 0.000 claims 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims 4
- 235000011130 ammonium sulphate Nutrition 0.000 claims 4
- 239000002244 precipitate Substances 0.000 claims 4
- 238000001556 precipitation Methods 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 239000006228 supernatant Substances 0.000 claims 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- 239000004382 Amylase Substances 0.000 claims 3
- 102000013142 Amylases Human genes 0.000 claims 3
- 108010065511 Amylases Proteins 0.000 claims 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims 3
- 108091005804 Peptidases Proteins 0.000 claims 3
- 239000004365 Protease Substances 0.000 claims 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 3
- 235000019418 amylase Nutrition 0.000 claims 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- 239000012062 aqueous buffer Substances 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000001376 precipitating effect Effects 0.000 claims 2
- 238000003756 stirring Methods 0.000 claims 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 239000004367 Lipase Substances 0.000 claims 1
- 102000004882 Lipase Human genes 0.000 claims 1
- 108090001060 Lipase Proteins 0.000 claims 1
- 229920005654 Sephadex Polymers 0.000 claims 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 claims 1
- 230000029936 alkylation Effects 0.000 claims 1
- 238000005804 alkylation reaction Methods 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 238000010908 decantation Methods 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 claims 1
- 238000002523 gelfiltration Methods 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 230000005865 ionizing radiation Effects 0.000 claims 1
- 235000019421 lipase Nutrition 0.000 claims 1
- 239000006193 liquid solution Substances 0.000 claims 1
- 239000006194 liquid suspension Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000002906 microbiologic effect Effects 0.000 claims 1
- 239000004005 microsphere Substances 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 230000004962 physiological condition Effects 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 1
- -1 sachets Substances 0.000 claims 1
- 239000012047 saturated solution Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/94—Pancreatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361900092P | 2013-11-05 | 2013-11-05 | |
| US61/900,092 | 2013-11-05 | ||
| PCT/US2014/063984 WO2015069677A1 (en) | 2013-11-05 | 2014-11-05 | High potency pancreatin pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2015155470A true RU2015155470A (ru) | 2017-08-21 |
| RU2015155470A3 RU2015155470A3 (https=) | 2018-09-10 |
Family
ID=53042009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015155470A RU2015155470A (ru) | 2013-11-05 | 2014-11-05 | Высокоэффективные фармацевтические композиции панкреатина |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP3613429A1 (https=) |
| JP (1) | JP2017500885A (https=) |
| KR (1) | KR20170052520A (https=) |
| CN (1) | CN106659773A (https=) |
| AU (1) | AU2014346930A1 (https=) |
| BR (1) | BR112016000658A2 (https=) |
| CA (1) | CA2915671A1 (https=) |
| ES (1) | ES2834483T3 (https=) |
| HK (1) | HK1222325A1 (https=) |
| IL (3) | IL243435B (https=) |
| MX (1) | MX2016000480A (https=) |
| RU (1) | RU2015155470A (https=) |
| WO (1) | WO2015069677A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
| US8246950B2 (en) | 2007-02-20 | 2012-08-21 | Aptalis Pharma Limited | Stable digestive enzyme compositions |
| WO2009109856A2 (en) | 2008-03-07 | 2009-09-11 | Axcan Pharma Inc. | Method for detecting infectious parvovirus in pharmaceutical preparations |
| UA111726C2 (uk) | 2010-10-01 | 2016-06-10 | Апталіс Фарма Лімітед | Препарат панкреліпази низької сили з кишковорозчинним покриттям |
| CA2843556A1 (en) | 2011-08-08 | 2013-02-14 | Aptalis Pharma Ltd. | Method for dissolution testing of solid compositions containing digestive enzymes |
| WO2015019198A2 (en) | 2013-07-22 | 2015-02-12 | Aptalis Pharma S.R.L. | High potency pancreatin pharmaceutical compositions |
| MX2016001593A (es) | 2013-08-09 | 2016-09-29 | Allergan Pharmaceuticals Int Ltd | Composicion de enzima digestiva adecuada para administracion enterica. |
| JP2017519490A (ja) * | 2014-06-19 | 2017-07-20 | アプタリス ファルマ リミテッド | 膵臓抽出物からのウイルス汚染の除去方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2751330A (en) * | 1952-08-27 | 1956-06-19 | Armour & Co | Use of a salt in the extraction slurry in recovering proteolytic enzymes from pancreas gland material |
| GB928654A (en) | 1960-10-25 | 1963-06-12 | Philips Nv | Improvements in or relating to the production of pancreatin |
| US3168448A (en) | 1963-01-07 | 1965-02-02 | Wilson & Co Inc | Process of preparing a lipolytic enzyme composition |
| DE2460334C3 (de) * | 1974-12-20 | 1979-09-06 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Gewinnung von Insulin und Pankreatin aus Schweinepankreas |
| EP0115023B1 (de) * | 1982-12-30 | 1988-07-27 | Nordmark Arzneimittel GmbH | Verfahren zur Gewinnung von Pankreatin |
| FR2603804B1 (fr) * | 1986-09-17 | 1989-10-27 | Jouveinal Sa | Lipases et extraits lipasiques, leur procede de preparation et leur application en therapeutique |
| DE3927286C2 (de) * | 1989-08-18 | 1997-07-24 | Roehm Gmbh | Wäßrige Enzym-Flüssigformulierungen |
| US6051220A (en) | 1995-05-31 | 2000-04-18 | Medzyme N.V. And Simon Lodewijk Scharpe | Composition to improve digestibility and utilization of nutrients |
| US5750104A (en) * | 1996-05-29 | 1998-05-12 | Digestive Care Inc. | High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith |
| DE19724845A1 (de) * | 1996-08-28 | 1998-03-05 | Solvay Pharm Gmbh | Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen |
| US20010046493A1 (en) | 2000-02-24 | 2001-11-29 | Alex Margolin | Lipase-containing composition and methods of use thereof |
| AR032392A1 (es) * | 2001-01-19 | 2003-11-05 | Solvay Pharm Gmbh | Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado. |
| CA2419572A1 (en) * | 2003-02-18 | 2004-08-18 | Axcan Pharma Inc. | High dosage protease formulation |
| US20060198838A1 (en) * | 2004-09-28 | 2006-09-07 | Fallon Joan M | Combination enzyme for cystic fibrosis |
| PT1809320E (pt) * | 2004-10-14 | 2010-10-25 | Altus Pharmaceuticals Inc | Composições contendo lipase, protease e amilase para o tratamento de insuficiência pancreática |
| HUE031042T2 (en) | 2005-07-29 | 2017-06-28 | Abbott Laboratories Gmbh | Methods for producing pancreatin powder with low viral content |
| US8246950B2 (en) * | 2007-02-20 | 2012-08-21 | Aptalis Pharma Limited | Stable digestive enzyme compositions |
| RU2012142134A (ru) * | 2010-03-19 | 2014-04-27 | Апталис Фарма Кэнэда Инк. | Желудочно-резистентные ферментные фармацевтические композиции |
| AU2011248293A1 (en) * | 2010-05-03 | 2012-11-15 | Eurand Pharmaceuticals Limited | Micropellet compositions comprising pancreatin containing digestive enzyme mixtures |
| UA111726C2 (uk) * | 2010-10-01 | 2016-06-10 | Апталіс Фарма Лімітед | Препарат панкреліпази низької сили з кишковорозчинним покриттям |
| CN103060297B (zh) * | 2012-12-28 | 2014-06-25 | 青岛九龙生物医药有限公司 | 一种分离纯化胰蛋白酶的方法 |
| CN103060296B (zh) * | 2012-12-30 | 2014-05-21 | 青岛九龙生物医药有限公司 | 从动物胰脏中提取胰蛋白酶的方法 |
| WO2015019198A2 (en) | 2013-07-22 | 2015-02-12 | Aptalis Pharma S.R.L. | High potency pancreatin pharmaceutical compositions |
-
2014
- 2014-11-05 MX MX2016000480A patent/MX2016000480A/es unknown
- 2014-11-05 ES ES14859866T patent/ES2834483T3/es active Active
- 2014-11-05 CA CA2915671A patent/CA2915671A1/en active Pending
- 2014-11-05 JP JP2016552457A patent/JP2017500885A/ja active Pending
- 2014-11-05 CN CN201480040273.7A patent/CN106659773A/zh active Pending
- 2014-11-05 AU AU2014346930A patent/AU2014346930A1/en not_active Abandoned
- 2014-11-05 EP EP19201877.8A patent/EP3613429A1/en not_active Withdrawn
- 2014-11-05 KR KR1020167001052A patent/KR20170052520A/ko not_active Withdrawn
- 2014-11-05 HK HK16110490.6A patent/HK1222325A1/zh unknown
- 2014-11-05 WO PCT/US2014/063984 patent/WO2015069677A1/en not_active Ceased
- 2014-11-05 RU RU2015155470A patent/RU2015155470A/ru not_active Application Discontinuation
- 2014-11-05 EP EP14859866.7A patent/EP3003360B1/en not_active Revoked
- 2014-11-05 BR BR112016000658A patent/BR112016000658A2/pt not_active Application Discontinuation
-
2015
- 2015-12-31 IL IL243435A patent/IL243435B/en active IP Right Grant
-
2020
- 2020-05-11 IL IL274583A patent/IL274583B/en unknown
-
2021
- 2021-06-27 IL IL284419A patent/IL284419A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL243435A0 (en) | 2016-03-31 |
| AU2014346930A1 (en) | 2016-01-07 |
| EP3613429A1 (en) | 2020-02-26 |
| MX2016000480A (es) | 2016-10-21 |
| HK1222325A1 (zh) | 2017-06-30 |
| EP3003360A4 (en) | 2017-04-26 |
| IL274583A (en) | 2020-06-30 |
| CA2915671A1 (en) | 2015-05-14 |
| IL243435B (en) | 2020-06-30 |
| WO2015069677A1 (en) | 2015-05-14 |
| JP2017500885A (ja) | 2017-01-12 |
| IL284419A (en) | 2021-07-29 |
| IL274583B (en) | 2022-06-01 |
| RU2015155470A3 (https=) | 2018-09-10 |
| CN106659773A (zh) | 2017-05-10 |
| KR20170052520A (ko) | 2017-05-12 |
| BR112016000658A2 (pt) | 2018-03-20 |
| EP3003360A1 (en) | 2016-04-13 |
| EP3003360B1 (en) | 2020-10-07 |
| ES2834483T3 (es) | 2021-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015155470A (ru) | Высокоэффективные фармацевтические композиции панкреатина | |
| RU2016101760A (ru) | Высокоэффективные фармацевтические композиции панкреатина | |
| JP2017500885A5 (https=) | ||
| CN102847134B (zh) | 小球藻多肽微胶囊的制备方法 | |
| RU2012142140A (ru) | Бета-пропиолактон для инактивации вирусов в фармацевтических препаратах фермента поджелудочной железы | |
| JP2016527247A5 (https=) | ||
| CN114846147B (zh) | 低分子量硫酸软骨素、包含其的组合物、其制备方法以及其用途 | |
| Pretto et al. | Cowpea chlorotic mottle virus‐like particles as potential platform for antisense oligonucleotide delivery in posterior segment ocular diseases | |
| CN101991541A (zh) | 阿昔洛韦-壳聚糖纳米粒的制备方法 | |
| AU2021257255A1 (en) | Regenerative nonsteroidal anti-inflammatory compositions, methods of production, and methods of use thereof | |
| CN106243239B (zh) | 一种用于提高肝炎患者免疫力的可溶性小分子β-1,3-葡聚糖 | |
| CN105663092A (zh) | 一种含有他克莫司固体分散体的缓释胶囊及其制备方法 | |
| CN110897998B (zh) | 一种同时载有疏水性药物和亲水性药物的基因工程多肽纳米水凝胶及其制备方法 | |
| CN102872462B (zh) | 一种盐酸氨溴索组合物及其制剂 | |
| CN102293748B (zh) | 一种口服聚乙二醇化胰岛素pH敏感纳米粒及其制备方法 | |
| CN114569564A (zh) | 戈舍瑞林缓释微球组合物 | |
| CN102526168B (zh) | 一种叶下珠抗流感病毒有效部位微囊及其制备方法和应用 | |
| CN101829065B (zh) | 注射用兰索拉唑组合物冻干粉 | |
| US20180221451A1 (en) | Long acting liraglutide compositions | |
| CN102552216A (zh) | 一种蛇毒镇痛多肽纳米囊及其制备方法和应用 | |
| Darveshwar Jagdeep et al. | Review on applications of polymers in pharmaceutical formulations | |
| RU2791688C1 (ru) | Способ получения модифицированного крахмала | |
| CN104013582A (zh) | 一种阿司匹林peg-plga微球及其制备方法 | |
| CN103301451B (zh) | 一种皮内注射用布氏菌活疫苗冻干保护剂 | |
| CN103923208B (zh) | 一种重组人角质细胞生长因子-2突变体的活性稳定剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20190326 |